Feature|Articles|September 17, 2024
- Pharmaceutical Executive: September 2024
- Volume 44
- Issue 9
Pharmaceutical Executive: September 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive September 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
A Care Sea Changeover 1 year ago
Jan van de Winkel: Antibody Ascensionover 1 year ago
Biotech Performance Pivot May Be in the Offingover 1 year ago
Delivery and Disruption: Navigating a Changing Care Terrainover 1 year ago
Outsourcing’s Evolution in the Pharma Industryover 1 year ago
A Risk-Reward Reset: Getting Serious About Social Mediaover 1 year ago
Copay Adjustment Chess Match: What Will Payers Do Next?over 1 year ago
Rx Power Struggle: How Pharma can Flip the PBM ScriptNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
What Unexpected Costs do GLP-1 Patients Face?
5